Intravenous administration of bone marrow-derived mesenchymal stem cells induces a switch from classical to atypical symptoms in experimental autoimmune encephalomyelitis.
Kurte M, Bravo-Alegría J, Torres A, Carrasco V, Ibáñez C, Vega-Letter A M, Fernández-O'Ryan C, Irarrázabal CE, Figueroa FE, Fuentealba RA, et al.